Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Foreword to the special issue on advances in neuroendocrine neoplasmsReviews in endocrine & metabolic disorders, 2021-09, Vol.22 (3), p.493-494 [Peer Reviewed Journal]The Author(s) 2021 ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1389-9155 ;EISSN: 1573-2606 ;DOI: 10.1007/s11154-021-09639-z ;PMID: 33712996Full text available |
|
2 |
Material Type: Article
|
Editorial-Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and EducationFrontiers in endocrinology (Lausanne), 2021-07, Vol.12, p.722145-722145 [Peer Reviewed Journal]Copyright © 2021 Faggiano and Colao 2021 Faggiano and Colao ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2021.722145 ;PMID: 34276572Full text available |
|
3 |
Material Type: Article
|
Vitamin D testing: advantages and limits of the current assaysEuropean journal of clinical nutrition, 2020-02, Vol.74 (2), p.231-247 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;2020© The Author(s), under exclusive licence to Springer Nature Limited 2020 ;ISSN: 0954-3007 ;ISSN: 1476-5640 ;EISSN: 1476-5640 ;DOI: 10.1038/s41430-019-0553-3 ;PMID: 31907366Full text available |
|
4 |
Material Type: Article
|
Management of Functional Pancreatic Neuroendocrine NeoplasmsCurrent treatment options in oncology, 2023-07, Vol.24 (7), p.725-741 [Peer Reviewed Journal]The Author(s) 2023 ;ISSN: 1527-2729 ;EISSN: 1534-6277 ;DOI: 10.1007/s11864-023-01085-0Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective StudyThe journal of clinical endocrinology and metabolism, 2019-06, Vol.104 (6), p.2367-2374 [Peer Reviewed Journal]Copyright © 2019 Endocrine Society 2019 ;Copyright © 2019 Endocrine Society. ;COPYRIGHT 2019 Oxford University Press ;Copyright © 2019 Endocrine Society ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2018-01968 ;PMID: 30715419Full text available |
|
6 |
Material Type: Article
|
Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) AggressivenessNutrients, 2018-12, Vol.10 (12), p.1854 [Peer Reviewed Journal]2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 by the authors. 2018 ;ISSN: 2072-6643 ;EISSN: 2072-6643 ;DOI: 10.3390/nu10121854 ;PMID: 30513732Full text available |
|
7 |
Material Type: Article
|
Understanding care relationships in diabetes practice: A psychodynamic interview-based exploratory studyPloS one, 2022-02, Vol.17 (2), p.e0263226-e0263226 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 Marchini et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Marchini et al 2022 Marchini et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0263226 ;PMID: 35176064Full text available |
|
8 |
Material Type: Article
|
Pasireotide in the treatment of neuroendocrine tumors: a review of the literatureEndocrine-related cancer, 2018-06, Vol.25 (6), p.R351-R364 [Peer Reviewed Journal]2018 Society for Endocrinology ;2018 Society for Endocrinology. ;ISSN: 1351-0088 ;EISSN: 1479-6821 ;DOI: 10.1530/ERC-18-0010 ;PMID: 29643113Full text available |
|
9 |
Material Type: Article
|
Carcinoid Syndrome: Preclinical Models and Future Therapeutic StrategiesInternational journal of molecular sciences, 2023-02, Vol.24 (4), p.3610 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms24043610 ;PMID: 36835022Full text available |
|
10 |
Material Type: Article
|
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine TumorsFrontiers in endocrinology (Lausanne), 2021-03, Vol.12, p.649496-649496 [Peer Reviewed Journal]Copyright © 2021 Barrea, Muscogiuri, Modica, Altieri, Pugliese, Minotta, Faggiano, Colao and Savastano. ;Copyright © 2021 Barrea, Muscogiuri, Modica, Altieri, Pugliese, Minotta, Faggiano, Colao and Savastano 2021 Barrea, Muscogiuri, Modica, Altieri, Pugliese, Minotta, Faggiano, Colao and Savastano ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2021.649496 ;PMID: 33815296Full text available |
|
11 |
Material Type: Article
|
Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?Journal of translational medicine, 2021-07, Vol.19 (1), p.1-324, Article 324 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1479-5876 ;EISSN: 1479-5876 ;DOI: 10.1186/s12967-021-03010-1 ;PMID: 34330303Full text available |
|
12 |
Material Type: Article
|
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future ApproachesFrontiers in endocrinology (Lausanne), 2021-07, Vol.12, p.651438-651438 [Peer Reviewed Journal]Copyright © 2021 Lania, Ferraù, Rubino, Modica, Colao and Faggiano. ;Copyright © 2021 Lania, Ferraù, Rubino, Modica, Colao and Faggiano 2021 Lania, Ferraù, Rubino, Modica, Colao and Faggiano ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2021.651438 ;PMID: 34381421Full text available |
|
13 |
Material Type: Article
|
Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studiesTranslational oncology, 2022-01, Vol.15 (1), p.101269-101269, Article 101269 [Peer Reviewed Journal]2021 ;Copyright © 2021. Published by Elsevier Inc. ;2021 The Authors. Published by Elsevier Inc. 2021 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2021.101269 ;PMID: 34794032Full text available |
|
14 |
Material Type: Article
|
Thyroid transcription factor‐1 expression in lung neuroendocrine tumours: a gender-related biomarker?Endocrine, 2024-02, Vol.83 (2), p.519-526 [Peer Reviewed Journal]The Author(s) 2023 ;EISSN: 1559-0100 ;DOI: 10.1007/s12020-023-03542-0Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Hashimoto’s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancerEndocrine-related cancer, 2017-09, Vol.24 (9), p.485-493 [Peer Reviewed Journal]2017 Society for Endocrinology ;2017 Society for Endocrinology. ;ISSN: 1351-0088 ;EISSN: 1479-6821 ;DOI: 10.1530/ERC-17-0085 ;PMID: 28696209Full text available |
|
16 |
Material Type: Article
|
Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?Frontiers in endocrinology (Lausanne), 2021-04, Vol.12, p.667784-667784 [Peer Reviewed Journal]Copyright © 2021 Di Molfetta, Dotto, Fanciulli, Florio, Feola, Colao and Faggiano. ;Copyright © 2021 Di Molfetta, Dotto, Fanciulli, Florio, Feola, Colao and Faggiano 2021 Di Molfetta, Dotto, Fanciulli, Florio, Feola, Colao and Faggiano ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2021.667784 ;PMID: 33935977Full text available |
|
17 |
Material Type: Article
|
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PETClinical endocrinology (Oxford), 2013-05, Vol.78 (5), p.760-767 [Peer Reviewed Journal]2012 Blackwell Publishing Ltd ;2014 INIST-CNRS ;2012 Blackwell Publishing Ltd. ;Copyright © 2013 Blackwell Publishing Ltd ;ISSN: 0300-0664 ;EISSN: 1365-2265 ;DOI: 10.1111/cen.12057 ;PMID: 23009688 ;CODEN: CLECAPFull text available |
|
18 |
Material Type: Article
|
Erectile Dysfunction Severity: The Role of Glycometabolic Compensation and Antihyperglycemic DrugsJournal of clinical medicine, 2022-12, Vol.11 (23), p.7214 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm11237214 ;PMID: 36498788Full text available |
|
19 |
Material Type: Article
|
Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?Frontiers in endocrinology (Lausanne), 2021-07, Vol.12, p.672499-672499 [Peer Reviewed Journal]Copyright © 2021 Giannetta, La Salvia, Rizza, Muscogiuri, Campione, Pozza, Colao and Faggiano. ;Copyright © 2021 Giannetta, La Salvia, Rizza, Muscogiuri, Campione, Pozza, Colao and Faggiano 2021 Giannetta, La Salvia, Rizza, Muscogiuri, Campione, Pozza, Colao and Faggiano ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2021.672499 ;PMID: 34367064Full text available |
|
20 |
Material Type: Article
|
Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumorsJournal of translational medicine, 2023-08, Vol.21 (1), p.1-548, Article 548 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1479-5876 ;EISSN: 1479-5876 ;DOI: 10.1186/s12967-023-04417-8Full text available |